Zullo Investment Group, Inc. Heron Therapeutics, Inc. Transaction History

Zullo Investment Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $6,750 - $14,010	-3,000 Reduced 46.51%	3,450 $8,000
Q2 2022 Aug 11, 2022	BUY	$2.3 - $6.29 $345 - $943	150 Added 2.38%	6,450 $18,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $13,890 - $29,820	3,000 Added 90.91%	6,300 $36,000
Q4 2021 Feb 16, 2022	BUY	$8.35 - $12.6 $27,555 - $41,580	3,300 New	3,300 $30,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Zullo Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Zullo Investment Group, Inc. with notifications on news.